Kuala Lumpur - Delayed Quote • MYR Farm Fresh Berhad (5306.KL) Follow Compare 1.8200 -0.0100 (-0.55%) At close: 4:51:10 PM GMT+8 Related News Stock market today: Nasdaq futures slide, S&P 500 backs off from record as techs lose steam Stocks are faltering as markets stay focused on what Trump's next move could be. Trump addresses Davos, American Airlines earnings: What to Watch Market Domination Overtime anchors Julie Hyman and Josh Lipton preview key market events for Thursday, January 23. President Trump will virtually address the global leaders attending the 2025 World Economic Forum in Davos, Switzerland. He is expected to speak at 11 am ET. The earnings calendar features pre-market releases from GE Aerospace (GE), American Airlines (AAL), Alaska Airlines (AAL), and Union Pacific (UNP). After the closing bell, investors will analyze results from semiconductor giant Texas Instruments (TXN) and railroad operator CSX (CSX). On the economic calendar, a new weekly initial jobless claims will be released, with investors expecting a figure of 220,000. Additionally, new mortgage rate data will offer a fresh perspective on the housing market's trajectory. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome Four Weeks After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured Endpoints ObservedData Supports QRX003 Mechanism of Action as a Competitive Broad Spectrum Serine Protease Inhibitor ASHBURN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces further clinical evidence of th McCormick Posts 3% Sales Growth In Q4 As Consumer Demand Rise McCormick & Co Inc (NYSE:MKC) reported fourth-quarter sales growth of 3% year-on-year to $1.798 billion, beating the analyst consensus estimate of $1.77 billion. Flavor Solutions segment sales grew by 1%, with minimal impact from currency. Consumer segment sales increased 4%. Gross profit was $722.2 million, with the margin expanding 20 basis points Y/Y to 40.2%. Operating income rose 3% to $306.2 million and the operating margin remained flat at 17%. Adjusted EPS of $0.80 beat the consensus est Cholula maker McCormick forecasts tepid annual sales, profit on slowing demand, rising expenses Packaged food companies including McCormick, General Mills and Conagra Brands have also faced slowing demand across geographies as sticky inflation has compelled budget-conscious customers to hunt for value even for essential items such as groceries. Increased marketing and advertising efforts have also taken a toll on the company's profit expectations, with costs rising 2.3% in the fourth quarter. GE Aerospace Q4 Earnings: EPS Beat, Dividend And Stock Buyback Hike, Strong FY25 Outlook And More GE Aerospace (NYSE:GE) shares are trading higher premarket on Thursday after it reported fourth-quarter adjusted revenue growth of 16% year-over-year to $9.879 billion and GAAP revenue of $10.812 billion. The analyst consensus was $9.604 billion. Commercial Engines & Services revenue was $7.650 billion (+19% Y/Y) and Defense & Propulsion Technologies revenue totaled $2.523 billion (+4% Y/Y). Total orders increased 46% Y/Y to $15.5 billion, with Commercial Engines & Services +50% Y/Y and Defense Railroad operator Union Pacific's quarterly profit rises 7% (Reuters) -Railroad operator Union Pacific (UNP) reported a 7% increase in fourth-quarter profit on Thursday, helped by more grain and fertilizer shipments and core pricing gains. Union Pacific (NYSE:UNP) Reports Q4 In Line With Expectations Freight transportation company Union Pacific (NYSE:UNP) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $6.12 billion. Its GAAP profit of $2.91 per share was 4.4% above analysts’ consensus estimates. P180 assumes majority control of Vince Holding, Hoffman back as CEO P180, a new venture, has taken majority control in US luxury fashion company Vince Holding (VNCE) for an undisclosed amount, a move that will see Brendan Hoffman return to the brand as CEO. Union Pacific: Q4 Earnings Snapshot OMAHA, Neb. AP) — Union Pacific Corp. UNP) on Thursday reported fourth-quarter earnings of $1.76 billion. Union Pacific Reports Fourth Quarter and Full Year 2024 Results OMAHA, Neb., January 23, 2025--Union Pacific Corporation (NYSE: UNP) today reported 2024 fourth quarter net income of $1.8 billion, or $2.91 per diluted share. These results include $40 million of labor expense related to the ratification of a crew staffing agreement. This compares to 2023 fourth quarter net income of $1.7 billion, or $2.71 per diluted share. GE Aerospace Eyes Breakout On Booming Earnings, 2025 Guidance Engine, services and defense revenues all climbed. GE Aero also is hiking its dividend and set a stock buyback. American Airlines Posts Record Revenue, Beats Earnings Estimates. Why the Stock Is Tumbling. The carrier expects an adjusted loss of between 40 cents and 20 cents per share, steeper than the 4 cents per share loss estimated by Wall Street. Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. FEATURE Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly dividend. Elevance Health stock rose 4.4% to $408.03 in premarket trading Thursday. American Airlines (NASDAQ:AAL) Posts Better-Than-Expected Sales In Q4 But Stock Drops Global airline American Airlines (NASDAQ:AAL) announced better-than-expected revenue in Q4 CY2024, with sales up 4.6% year on year to $13.66 billion. Its non-GAAP profit of $0.86 per share was 30.1% above analysts’ consensus estimates. American Airlines: Q4 Earnings Snapshot FORT WORTH, Texas (AP) — American Airlines Group Inc. AAL) on Thursday reported fourth-quarter earnings of $590 million. On a per-share basis, the Fort Worth, Texas-based company said it had profit of 84 cents. Stocks Falter Pre-Bell as Investors Await More Earnings; Asia, Europe Mostly Rise The main US stock measures were mostly pointing lower before Thursday's opening bell as traders awai American Airlines forecasts downbeat 2025 profit on strategy misstep American Airlines forecast 2025 profit below Wall Street expectations as the carrier attempts to remedy a sales-strategy misstep that drove away corporate travelers, sending its shares down 7% premarket on Thursday. The aggressive approach, implemented in 2023, focused on renegotiating contracts with corporate travel agencies and clients while cutting back on perks and discounts. The plan dented revenue, hurt the airline's image and gave rivals an edge, forcing American to spend much of 2024 rebuilding its sales strategy and mending relationships with corporate travelers to regain some of the lost customers. American Airlines Reports Fourth-Quarter and Full-Year 2024 Financial Results FORT WORTH, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its fourth-quarter and full-year 2024 financial results, including: Record fourth-quarter revenue of $13.7 billion and record full-year revenue of $54.2 billionFourth-quarter and full-year GAAP net income of $590 million and $846 million, or $0.84 and $1.24 per diluted share, respectively Excluding net special items1, fourth-quarter and full-year net income of $609 million and $1.4 bill Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease - Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer’s disease (AD) - - Robust and dose-dependent reductions of sTREM2 were achieved demonstrating sustained functional target engagement – - Company plans to advance VG-3927 into a Phase 2 trial in the third quarter of 2025; Selects 25mg QD oral as a dose that fully engages desired pharmacology - WATERTOWN, Mass., Jan. 23, 2025 (GLOBE NEWSW Performance Overview Trailing total returns as of 1/23/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI Return 5306.KL FTSE Bursa Malaysia KLCI YTD -2.67% -3.69% 1-Year +33.50% +5.77% 3-Year +7.06% +3.28%